VeraTag™ Pipeline

VeraTag technology provides accurate quantification of HER protein expression to further improve individualized therapy. HERmark™ is the first CLIA validated assay based on VeraTag, other assays in development will provide additional information.

> For more information on VeraTag assays click here to contact us.